C.M.A. Swanink

4.1k total citations · 1 hit paper
36 papers, 2.8k citations indexed

About

C.M.A. Swanink is a scholar working on Epidemiology, Psychiatry and Mental health and Infectious Diseases. According to data from OpenAlex, C.M.A. Swanink has authored 36 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 14 papers in Psychiatry and Mental health and 10 papers in Infectious Diseases. Recurrent topics in C.M.A. Swanink's work include Fibromyalgia and Chronic Fatigue Syndrome Research (14 papers), Respiratory viral infections research (8 papers) and Health, psychology, and well-being (7 papers). C.M.A. Swanink is often cited by papers focused on Fibromyalgia and Chronic Fatigue Syndrome Research (14 papers), Respiratory viral infections research (8 papers) and Health, psychology, and well-being (7 papers). C.M.A. Swanink collaborates with scholars based in Netherlands, Switzerland and Sweden. C.M.A. Swanink's co-authors include Gijs Bleijenberg, J.F.M. Fennis, Jan H. Vercoulen, Joep M.D. Galama, Jos W.M. van der Meer, J M Galama, J.W.M. van der Meer, J W van der Meer, Peter Joseph Jongen and Paul E. Verweij and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

C.M.A. Swanink

34 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dimensional assessment of chronic fatigue syndrome

1994 1.0k citations Jan H. Vercoulen, C.M.A. Swanink et al. Journal of Psychosomatic Research profile →

Peers

Countries citing papers authored by C.M.A. Swanink

Since Specialization

Citations

This map shows the geographic impact of C.M.A. Swanink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.M.A. Swanink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.M.A. Swanink more than expected).

Fields of papers citing papers by C.M.A. Swanink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.M.A. Swanink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.M.A. Swanink. The network helps show where C.M.A. Swanink may publish in the future.

Co-authorship network of co-authors of C.M.A. Swanink

This figure shows the co-authorship network connecting the top 25 collaborators of C.M.A. Swanink. A scholar is included among the top collaborators of C.M.A. Swanink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.M.A. Swanink. C.M.A. Swanink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Investigating two decades of Streptococcus pneumoniae bacteraemia in the Gelderland area, the Netherlands, using whole-genome sequencing 2025 ·Microbial Genomics ·(unknown), (unknown), Femke Wolters, Heiman Wertheim, Bert Mulder, C.M.A. Swanink, Christa E. van der Gaast‐de Jongh, (unknown), Nina M. van Sorge, (unknown), (unknown), Paulina A. Hawkins, Lesley McGee, Stephen D. Bentley, Jan‐Willem Veening, Marien I. de Jonge, (unknown), Amelieke J. H. Cremers	0
2	Optimization of the STARlet workflow for semi-automatic SARS-CoV-2 screening of swabs and deep respiratory materials using the RealAccurate Quadruplex SARS-CoV-2 PCR kit and Allplex SARS-CoV-2 PCR kit 2024 ·Microbiology Spectrum ·Jacky Flipse, Angelino T. Tromp, (unknown), (unknown), (unknown), (unknown), (unknown), C.M.A. Swanink	0
3	Short Communication: Prolonged COVID-19 Infection in a Patient with Newly Diagnosed HIV/AIDS 2022 ·AIDS Research and Human Retroviruses ·(unknown), (unknown), Mark A. A. Claassen, C.M.A. Swanink, (unknown), (unknown), Aart C. Strang, Robert‐Jan Hassing	7
4	C-reactive protein to rule out complicated pneumococcal disease manifestations: a retrospective cohort study in adults with pneumococcal bacteraemia 2021 ·International Journal of Infectious Diseases ·(unknown), (unknown), (unknown), Ron Bosboom, (unknown), Heiman Wertheim, Bert Mulder, Marien I. de Jonge, (unknown), C.M.A. Swanink, Amelieke J. H. Cremers	5
5	The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained. 2021 ·International Journal of Infectious Diseases ·(unknown), Bert Mulder, Annelies Post, Martijn Rutten, C.M.A. Swanink, Heiman Wertheim, Amelieke J. H. Cremers	13
6	Increased overall survival after introduction of structured bedside consultation in Staphylococcus aureus bacteraemia 2018 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown), Lian Roovers, Mark A. A. Claassen, Robert‐Jan Hassing, C.M.A. Swanink, Elisabeth H. Gisolf	9
7	Rapid Enterovirus Molecular Testing in Cerebrospinal Fluid Reduces Length of Hospitalization and Duration of Antibiotic Therapy in Children With Aseptic Meningitis 2011 ·The Pediatric Infectious Disease Journal ·(unknown), C.M.A. Swanink, Anneke M. Landstra, Anton A. van Zwet, (unknown)	20
8	Hepatitis B prevalence in the Turkish population of Arnhem: implications for national screening policy? 2011 ·Epidemiology and Infection ·Clemens Richter, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), C.M.A. Swanink, Lian Roovers	25
9	Primary haemochromatosis: a missed cause of chronic fatigue syndrome? 2002 ·PubMed ·Dorine W. Swinkels, (unknown), L.D. Elving, Gijs Bleijenberg, C.M.A. Swanink, J.W.M. van der Meer	12
10	Yersinia enterocolitica and the chronic fatigue syndrome 1998 ·Journal of Infection ·C.M.A. Swanink, (unknown), J.W.M. van der Meer, Jan H. Vercoulen, Gijs Bleijenberg, J.F.M. Fennis, J M Galama, J. A. A. Hoogkamp‐Korstanje	5
11	The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis 1998 ·Journal of Psychosomatic Research ·Jan H. Vercoulen, C.M.A. Swanink, J M Galama, J.F.M. Fennis, Peter Joseph Jongen, O. R. Hommes, J.W.M. van der Meer, Gijs Bleijenberg	197
12	Physical activity in chronic fatigue syndrome: Assessment and its role in fatigue 1997 ·Journal of Psychiatric Research ·Jan H. Vercoulen, Ellen Bazelmans, C.M.A. Swanink, J.F.M. Fennis, J M Galama, Peter Joseph Jongen, O.R. Hommes, J.W.M. van der Meer, Gijs Bleijenberg	177
13	SEVERE NEONATAL ECHOVIRUS 20 INFECTION CHARACTERIZED BY HEPATIC FAILURE 1997 ·The Pediatric Infectious Disease Journal ·(unknown), C.M.A. Swanink, Tannette G. Krediet, Anton M. van Loon, H. Brüning, J A Kaan, Leo J. Gerards, J M Galama, A. Fleer	18
14	Lymphocyte Subsets, Apoptosis, and Cytokines in Patients with Chronic Fatigue Syndrome 1996 ·The Journal of Infectious Diseases ·C.M.A. Swanink, Jan H. Vercoulen, J M Galama, Marijke Roos, Linde Meyaard, Johanna van der Ven‐Jongekrijg, (unknown), Gijs Bleijenberg, J.F.M. Fennis, Frank Miedema, J W van der Meer	70
15	Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome 1996 ·The Lancet ·Jan H. Vercoulen, (unknown), Gijs Bleijenberg, C.M.A. Swanink, Stephen Vreden, J.F.M. Fennis, J.W.M. van der Meer, J M Galama, Frans G. Zitman	181
16	Respiratory syncytial virus pneumonia in an AIDS patient 1996 ·Infection ·André van der Ven, Reinout van Crevel, Gerben Bootsma, P.P. Koopmans, C.M.A. Swanink, J M Galama	2
17	Epstein-Barr Virus (EBV) and the Chronic Fatigue Syndrome: Normal Virus Load in Blood and Normal Immunologic Reactivity in the EBV Regression Assay 1995 ·Clinical Infectious Diseases ·C.M.A. Swanink, J.W.M. van der Meer, Jan H. Vercoulen, Gijs Bleijenberg, J.F.M. Fennis, J M Galama	33
18	Chronic fatigue syndrome: a clinical and laboratory study with a well matched control group 1995 ·Journal of Internal Medicine ·C.M.A. Swanink, Jan H. Vercoulen, Gijs Bleijenberg, J.F.M. Fennis, Joep M.D. Galama, J.W.M. van der Meer	52
19	Enteroviruses and the Chronic Fatigue Syndrome 1994 ·Clinical Infectious Diseases ·C.M.A. Swanink, Willem J. G. Melchers, J.W.M. van der Meer, Jan H. Vercoulen, Gijs Bleijenberg, J.F.M. Fennis, J M Galama	44
20	Dimensional assessment of chronic fatigue syndrome breakdown → 1994 ·Journal of Psychosomatic Research ·Jan H. Vercoulen, C.M.A. Swanink, J.F.M. Fennis, Joep M.D. Galama, Jos W.M. van der Meer, Gijs Bleijenberg	1042

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact